Dallah Healthcare Company Stock price

Equities

4004

SA135G51UI10

Healthcare Facilities & Services

End-of-day quote Saudi Arabian S.E. 06:00:00 2024-03-03 pm EST 5-day change 1st Jan Change
183.2 SAR -0.97% Intraday chart for Dallah Healthcare Company -1.51% +6.64%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
Sales 2023 * 2.93B 780M Sales 2024 * 3.25B 866M Capitalization 17.9B 4.77B
Net income 2023 * 351M 93.59M Net income 2024 * 427M 114M EV / Sales 2023 * 6.69 x
Net Debt 2023 * 1.68B 449M Net Debt 2024 * 1.69B 450M EV / Sales 2024 * 6.03 x
P/E ratio 2023 *
53.2 x
P/E ratio 2024 *
41.2 x
Employees -
Yield 2023 *
1.14%
Yield 2024 *
1.41%
Free-Float 34.08%
More Fundamentals * Assessed data
Dynamic Chart
Ayyan Investment Appoints Financial Adviser for Share Exchange Deal with Dallah Healthcare MT
Dallah Healthcare Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Dallah Healthcare Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Dallah Healthcare Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Dallah Healthcare Company completed the acquisition of an additional 18.98% stake in International Medical Centre. CI
Dallah Healthcare Company Approves Resignation of Fahad Bin Abdulaziz Al-Rabiah as Board of Directors and Compensation and Remuneration Committee CI
Dallah Healthcare Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Dallah Healthcare Company Approves Board Appointments CI
Dallah Healthcare Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Dallah Healthcare Company Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Dallah Healthcare Company Receives Ministry of Health's Approval to Increase the Operational Capacity of Dallah Namar Hospital by 150 Additional Beds CI
Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Dallah Healthcare Company signed of a non-binding memorandum of understanding to acquire an additional 18.98% stake in International Medical Centre. CI
Dallah Healthcare Company Reports Earnings Results for the Third Quarter Ended September 30, 2021 CI
More news
1 day-0.97%
1 week-1.51%
Current month-2.35%
1 month+9.70%
3 months+4.93%
6 months+27.22%
Current year+6.64%
More quotes
1 week
181.00
Extreme 181
187.60
1 month
167.60
Extreme 167.6
194.00
Current year
161.20
Extreme 161.2
194.00
1 year
131.40
Extreme 131.4
194.00
3 years
51.10
Extreme 51.1
194.00
5 years
34.75
Extreme 34.75
194.00
10 years
32.45
Extreme 32.4497
194.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 67 08-03-28
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - -
Members of the board TitleAgeSince
Director/Board Member - -
Chairman 72 93-12-31
Director/Board Member 43 16-10-20
More insiders
Date Price Change Volume
24-03-04 183.2 -0.97% 42,854
24-03-03 185 -1.39% 44,416
24-02-29 187.6 +0.64% 108,447
24-02-28 186.4 +1.86% 79,437
24-02-27 183 -1.61% 121,426

End-of-day quote Saudi Arabian S.E., March 03, 2024

More quotes
Dallah Healthcare Company SJSC, formerly Dallah Healthcare Co, is a Saudi Arabia-based company engaged in the provision and operation of healthcare programs and utilities. The Company operates in the following business segments: Hospitals; Medicines, and Head Office. The Hospitals? segment objectives are to own, manage, operate and maintain healthcare facilities. The Medicines? segment objectives are to import, distribute, wholesale and retail medicines, as well as manufacture medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging materials. The Head Office's segment objectives are to operate, manage and maintain healthcare facilities; wholesale and retail surgical equipment, artificial parts, handicapped and hospitals equipment, as well as other supporting services.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
9
Last Close Price
183.2 SAR
Average target price
147.3 SAR
Spread / Average Target
-19.62%
Consensus
  1. Stock
  2. Equities
  3. Stock Dallah Healthcare Company - Saudi Arabian S.E.
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW